Intrinsic Therapeutics Competitor Insights

Intrinsic Therapeutics is a medical device company focused on developing and marketing the Barricaid implant. Barricaid is an FDA-approved device designed to close large annular defects that remain after lumbar discectomy surgery. The company aims to reduce the incidence of reherniation and reoperation, improving patient outcomes and quality of life. They target spine surgeons as their primary customers, offering a solution to a significant problem in discectomy procedures. Intrinsic Therapeutics supports its product with clinical evidence, surgeon training programs (like the IDEAL Discectomy Symposium), and patient resources. They operate primarily in the US, with Barricaid not currently available in Europe. The company's mission is to reduce needless suffering by ensuring Barricaid is accessible to patients and surgeons.